GRANO, MARIA
 Distribuzione geografica
Continente #
EU - Europa 207
NA - Nord America 156
AS - Asia 76
OC - Oceania 1
Totale 440
Nazione #
US - Stati Uniti d'America 153
IT - Italia 60
SG - Singapore 55
IE - Irlanda 42
CZ - Repubblica Ceca 33
DE - Germania 30
CN - Cina 19
SE - Svezia 19
UA - Ucraina 8
FR - Francia 5
FI - Finlandia 4
CA - Canada 3
RU - Federazione Russa 3
AT - Austria 2
AU - Australia 1
GB - Regno Unito 1
HK - Hong Kong 1
IN - India 1
Totale 440
Città #
Dublin 42
Singapore 41
Brno 33
Munich 28
Boardman 20
Chandler 18
Nyköping 16
Bari 15
Ashburn 8
Los Angeles 6
Rome 6
San Severo 6
Jacksonville 5
Carpegna 4
Helsinki 4
Malden 3
Princeton 3
Shanghai 3
Dearborn 2
Douai 2
Milan 2
New York 2
Paris 2
Seattle 2
Toronto 2
Turin 2
Vienna 2
Wilmington 2
Gatchina 1
Hangzhou 1
Hong Kong 1
Jinhua 1
Kunming 1
London 1
Modena 1
Modugno 1
Nanchang 1
Pune 1
Redmond 1
Shenyang 1
St Petersburg 1
Tianjin 1
Vittuone 1
Wuxi 1
Totale 297
Nome #
Impairment of Bone Remodeling in LIGHT/TNFSF14-Deficient Mice 65
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 53
Irisin and Secondary Osteoporosis in Humans 45
The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs 40
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 31
Irisin levels correlate with bone mineral density in soccer players 18
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 18
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 17
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 16
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 15
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 15
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis 14
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 14
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 14
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 13
Irisin levels correlate with bone mineral density in soccer players 13
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 13
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 13
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 13
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 12
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 12
Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle 11
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 10
Systemic Administration of Recombinant Irisin Accelerates Fracture Healing in Mice 10
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 10
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 9
Shedding “light” on the link between bone and fat in obese children and adolescents 9
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 9
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 7
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity—An Italian Study 3
Totale 542
Categoria #
all - tutte 5.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.863


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 1 2 1 0 1 0 1 0
2020/202114 1 0 2 0 1 0 1 0 1 3 2 3
2021/202223 0 0 0 0 1 0 2 1 8 5 1 5
2022/2023168 6 3 7 4 5 10 0 16 57 6 53 1
2023/2024182 6 19 18 17 10 8 21 2 3 1 8 69
2024/2025137 40 9 13 31 44 0 0 0 0 0 0 0
Totale 542